BlogZone Get the app

Finance

RBC upgrades Lakefront Biotherapeutics stock rating on autoimmune drug potential

Investing.com 23 Sept 2026 1 views

BlogZone shows headlines and summaries from public news feeds. The full story is published by Investing.com.

Read the full story at Investing.com →

Enjoyed this?

Get more stories like this — and write your own — in the BlogZone app.

Get the app

More in Finance

Goldman Sachs just slashed its 2027 gold forecast. Here are the new numbers

Investing.com · 43 min ago

Eric Trump-backed robot soldier startup can't pay staff after founder borrowed $4.6 million from company to buy home

Eric Trump-backed robot startup Foundation Future Industries has run low on cash and missed payroll, as CEO Sankaet Pathak faces scrutiny over a $4.6 million company loan.

CNBC Finance · 54 min ago

Fifth District Bancorp director Sins sells $39,013 in stock

Investing.com · 1 hour ago